Browse > Article
http://dx.doi.org/10.7314/APJCP.2012.13.4.1365

HMGB1 Promotes the Synthesis of Pro-IL-1β and Pro-IL-18 by Activation of p38 MAPK and NF-κB Through Receptors for Advanced Glycation End-products in Macrophages  

He, Qiang (Institute of Integrated Traditional Medicine and Western Medicine, Beijing Friendship Hospital, Capital Medical University)
You, Hong (Liver Research Center, Beijing Friendship Hospital, Capital Medical University)
Li, Xin-Min (Liver Research Center, Beijing Friendship Hospital, Capital Medical University)
Liu, Tian-Hui (Liver Research Center, Beijing Friendship Hospital, Capital Medical University)
Wang, Ping (Liver Research Center, Beijing Friendship Hospital, Capital Medical University)
Wang, Bao-En (Institute of Integrated Traditional Medicine and Western Medicine, Beijing Friendship Hospital, Capital Medical University)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.13, no.4, 2012 , pp. 1365-1370 More about this Journal
Abstract
The high mobility group box-1 (HMGB1) protein and NALP3 inflammasome have been identified to play important roles in inflammation and cancer pathogenesis, but the relationships between the two and cancer remain unclear. The current study investigated the relationship between HMGB1 and the NALP3 inflammasome in THP-1 macrophages. HMGB1 was found unable to activate the NALP3 inflammasome and failed to induce the release of the IL-$1{\beta}$ and IL-18 in THP-1 macrophages. HMGB1 was also found significantly enhanced the activity of ATP to induce IL-$1{\beta}$ and IL-18 by the induction of increased expression of pro-IL-$1{\beta}$ and pro-IL-18. This process was dependent on activation of RAGE, MAPK p38 and NF-${\kappa}B$ signaling pathway. These results demonstrate that HMGB1 promotes the synthesis of pro-IL-$1{\beta}$ and pro-IL-18 in THP-1 macrophages by the activation of p38 MAPK and NF-${\kappa}B$ through RAGE. HMGB1 likely plays an important role in the first step of the release of the IL-$1{\beta}$ and IL-18, preparing for other cytokines to induce excessive release of IL-$1{\beta}$ and IL-18 which promote inflammation and cancer progression.
Keywords
High mobility group box1; NALP3 inflammasome; inflammation; cancer;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Andersson U, Wang H, Palmblad K, et al (2000). High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes. J Exp Med, 192, 565-70.   DOI
2 Bauernfeind FG, Horvath G, Stutz A, et al (2009). Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression. J Immunol, 183, 787-91.   DOI
3 Mantovani A, Allavena P, Sica A, Balkwill F (2008). Cancerrelated inflammation. Nature, 454, 436-44.   DOI   ScienceOn
4 Carrascal MT, Mendoza L, Valcarcel M, et al (2003). Interleukin-18 binding protein reduces b16 melanoma hepatic metastasis by neutralizing adhesiveness and growth factors of sinusoidal endothelium. Cancer Res, 63, 491-7.
5 Eissa SA, Zaki SA, El-Maghraby et al (2005). Importance of serum IL-18 and RANTES as markers for breast carcinoma progression. J Egypt Natl Canc Inst, 17, 51-5.
6 Klune JR, Dhupar R, Cardinal J, et al (2008). HMGB1: endogenous danger signaling. Mol Med, 14, 476-84.
7 Martinon F (2010). Signaling by ROS drives inflammasome activation. Eur J Immunol, 40, 616-9.   DOI   ScienceOn
8 Lewis AM, Varghese S, Xu H, et al (2006). Interleukin-1 and cancer progression: the emerging role of interleukin-1 receptor antagonist as a novel therapeutic agent in cancer treatment. J Transl Med, 4, 48.   DOI
9 Lotze MT, Tracey KJ (2005). High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat Rev Immunol, 5, 331-42.   DOI
10 Luan ZG, Zhang H, Yang PT, et al (2010). HMGB1 activates nuclear factor-kappaB signaling by RAGE and increases the production of TNF-alpha in human umbilical vein endothelial cells. Immunobiology, 215, 956-62.   DOI
11 Merendino RA, Gangemi S, Ruello A, et al (2001). Serum levels of interleukin-18 and sICAM-1 in patients affected by breast cancer: preliminary considerations. Int J Biol Markers, 16, 126-9.
12 Sha Y, Zmijewski J, Xu Z, et al (2008). HMGB1 develops enhanced proinflammatory activity by binding to cytokines. J Immunol, 180, 2531-7.   DOI
13 Okamoto M, Liu W, Luo Y, et al (2010). Constitutively active inflammasome in human melanoma cells mediating autoinflammation via caspase-1 processing and secretion of interleukin-1beta. J Biol Chem, 285, 6477-88.   DOI
14 Park JS, Gamboni-Robertson F, He Q, et al (2006). High mobility group box 1 protein interacts with multiple Tolllike receptors. Am J Physiol Cell Physiol, 290, C917-24.
15 Schroder K, Tschopp J (2010). The inflammasomes. Cell, 140, 821-32.   DOI
16 Wang P, Cong M, Liu TH, et al (2010). Primary isolated hepatic oval cells maintain progenitor cell phenotypes aftertwo-year prolonged cultivation. J Hepatol, 53, 863-71.   DOI
17 Sims GP, Rowe DC, Rietdijk ST, et al (2010). HMGB1 and RAGE in inflammation and cancer. Annu Rev Immunol, 28, 367-88.   DOI
18 Tang D, Kang R, 3rd ZHJ, et al (2010). High-mobility group box 1 and cancer. Biochim Biophys Acta, 1799, 131-40.   DOI
19 Tschopp J, Schroder K (2010). NLRP3 inflammasome activation: The convergence of multiple signalling pathways on ROS production. Nat Rev Immunol, 10, 210-5.   DOI   ScienceOn
20 Yang D, Chen Q, Yang H, et al (2007). High mobility group box-1 protein induces the migration and activation of human dendritic cells and acts as an alarmin. J Leukoc Biol, 81, 59-66.
21 Yang J, Chen L, Yang J, et al (2011). High mobility group box- 1 induces migration of vascular smooth muscle cells via TLR4-dependent PI3K/Akt pathway activation. Mol Biol Rep, 39, 3361-7.
22 Ye ZB, Ma T, Li H, et al (2007). Expression and significance of intratumoral interleukin-12 and interleukin-18 in human gastric carcinoma. World J Gastroenterol, 13, 1747-51.   DOI